Table 5 Seroprevalence of non-falciparum MSP-119 antibodies by age group
Age group (years) | 0–9 | 10–19 | 20–29 | 30–39 | ≥ 40 |
|---|---|---|---|---|---|
Overall N (%) | 300 (20.3) | 339 (23.1) | 289 (19.6) | 209 (14.2) | 334 (22.7) |
MSP-119 antibodies N (%) | |||||
P. malariae | 3 (1.0) | 4 (1.2) | 9 (3.1) | 2 (1.0) | 8 (2.4) |
P. ovale | 1 (0.3) | 2 (0.6) | 1 (0.3) | 1 (0.3) | 1 (0.3) |
P. vivax | 5 (1.7) | 3 (0.9) | 2 (0.7) | 0 | 0 |